1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,490 | 0,510 | 10.08. | |
| 0,480 | 0,510 | 08.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.08. | FibroBiologics reports 1H results | 5 | Seeking Alpha | ||
| 31.07. | FibroBiologics, Inc.: FibroBiologics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | 110 | GlobeNewswire (Europe) | HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development... ► Artikel lesen | |
| 31.07. | FibroBiologics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 28.07. | FibroBiologics files patent for multipotent cell generation method | 1 | Investing.com | ||
| 28.07. | FibroBiologics, Inc.: FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications | 2 | GlobeNewswire (USA) | ||
| 18.07. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.07. | RedChip Companies, Inc.: Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 352 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc. (NASDAQ:TBH) and FibroBiologics, Inc. (NASDAQ:FBLG) on the RedChip Small Stocks,... ► Artikel lesen | |
| FIBROBIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 11.07. | FibroBiologics, Inc.: FibroBiologics to Present at the Advanced Wound Care Summit USA | 2 | GlobeNewswire (USA) | ||
| 07.07. | FibroBiologics, Inc.: FibroBiologics' to Present at Exclusive Live Investor Webinar and Q&A Session on July 10 | 1 | GlobeNewswire (USA) | ||
| 03.07. | FibroBiologics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.07. | RedChip Companies, Inc.: Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 293 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc. (Nasdaq:FTHM) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks... ► Artikel lesen | |
| 16.06. | FibroBiologics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.06. | FibroBiologics, Inc.: FibroBiologics Closes Third $5 Million Tranche of $25 Million Financing | 2 | GlobeNewswire (USA) | ||
| 16.06. | FibroBiologics, Inc.: FibroBiologics to Present at the BIO International Convention 2025 | 3 | GlobeNewswire (USA) | ||
| 09.06. | FibroBiologics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 09.06. | FibroBiologics Appoints Jason Davis As CFO | 2 | RTTNews | ||
| 09.06. | FibroBiologics announces CFO appointment | 1 | Seeking Alpha | ||
| 09.06. | FibroBiologics appoints new CFO amid clinical trials | 1 | Investing.com | ||
| 09.06. | Fibrobiologics, Inc.: FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer | 230 | GlobeNewswire (Europe) | HOUSTON, June 09, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development... ► Artikel lesen | |
| 16.05. | Fibrobiologics, Inc.: FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 96,15 | +0,16 % | Ihre wichtigsten Termine: Tyson Foods, Biontech, Adtran, Loews, VDMA und Stabilus stehen heute im Fokus! | © Foto: UnsplashGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Luxemburg:... ► Artikel lesen | |
| CUREVAC | 4,660 | -0,09 % | EQS-News: CureVac kündigt Einigung zur Beilegung des Patentstreits mit Pfizer/BioNTech an | Emittent / Herausgeber: CureVac
/ Schlagwort(e): Patent
CureVac kündigt Einigung zur Beilegung des Patentstreits mit Pfizer/BioNTech an
08.08.2025 / 02:15 CET/CEST
Für... ► Artikel lesen | |
| MODERNA | 22,460 | +0,04 % | Moderna nach Zahlen: Ist die Zukunft düster? | Moderna galt während der COVID-19-Pandemie als einer der großen Gewinner und avancierte mit seiner mRNA-Technologie und dem Impfstoff SpikeVax zu einem der führenden Biotechnologieunternehmen der Welt.... ► Artikel lesen | |
| PAION | 0,010 | 0,00 % | Paion Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| NOVAVAX | 7,220 | +0,36 % | Novavax, Inc.: Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights | Total revenue of $239 million in the second quarter of 2025
Received FDA BLA approval for Nuvaxovid, the only recombinant protein-based, non-mRNA COVID-19 vaccine... ► Artikel lesen | |
| 4SC | 0,550 | +3,77 % | PTA-News: 4SC AG: 4SC veröffentlicht Halbjahresbericht 2025 | DJ PTA-News: 4SC AG: 4SC veröffentlicht Halbjahresbericht 2025
Unternehmensmitteilung für den Kapitalmarkt
4SC AG: 4SC veröffentlicht Halbjahresbericht 2025
Planegg-Martinsried (pta000/08.08.2025/07:30... ► Artikel lesen | |
| NANOREPRO | 1,600 | +3,56 % | EQS-DD: NanoRepro AG: Lisa Jüngst, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
05.08.2025 / 14:00... ► Artikel lesen | |
| VIVOSIM LABS | 1,220 | -100,00 % | VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen | |
| INOVIO PHARMACEUTICALS | 1,210 | 0,00 % | INOVIO Pharma Announces Proposed Public Offering | WASHINGTON (dpa-AFX) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof)... ► Artikel lesen | |
| INFLARX | 0,700 | +0,57 % | InflaRx N.V.: InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update | INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025Phase 1/2 data announced by Staidson BioPharmaceuticals... ► Artikel lesen | |
| SCORPIUS | 0,072 | 0,00 % | Scorpius Holdings, Inc.: Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia | Operational Realignment Expected to Deliver Over $6 Million in Annual Cost Savings Company Exploring CDMO Expansion Opportunities in Southeast Asia San Antonio, TX, May 04, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,361 | -2,96 % | Defence Therapeutics Inc.: Defence's Accum Technology with ADC and Radiopharmaceutical Programs Target Cancer | Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 7,228 | +1,32 % | BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted... ► Artikel lesen | |
| DYNAVAX | 10,100 | +13,87 % | Dynavax Technologies: Dynavax Reports Second Quarter 2025 Financial Results | Record HEPLISAV-B® quarterly net product revenue of $92 million, representing 31% year-over-year growth
Refines full year 2025 HEPLISAV-B net product revenue... ► Artikel lesen | |
| REDHILL BIOPHARMA | 1,160 | -0,85 % | RedHill Biopharma Ltd.: RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease | The positive FDA feedback allows for:
A novel Phase 2 RHB-204[1] study, planned to be the first ever clinical study in a specifically defined Mycobacterium avium... ► Artikel lesen |
Das Unternehmen FIBROBIOLOGICS INC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,470 Euro und damit -4,86 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIBROBIOLOGICS INC finden Sie auf Wallstreet Online.